In January 2026, Microsoft Defender Experts identified a new evolution in the ongoing ClickFix campaign. This updated tactic deliberately crashes victims’ browsers and then attempts to lure users into ...
Infostealer threats are rapidly expanding beyond traditional Windows-focused campaigns, increasingly targeting macOS environments, leveraging cross-platform languages such as Python, and abusing ...
Recursive Language Models aim to break the usual trade off between context length, accuracy and cost in large language models. Instead of forcing a model to read a giant prompt in one pass, RLMs treat ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Python, like most other programming languages, has special operators for performing bitwise operations on data. A bitwise operation is an operation that is applied to individual bits of some object.
What if the programming language you rely on most is on the brink of a transformation? For millions of developers worldwide, Python is not just a tool, it’s a cornerstone of their craft, powering ...
Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...
Soon to be the official tool for managing Python installations on Windows, the new Python Installation Manager picks up where the ‘py’ launcher left off. Python is a first-class citizen on Microsoft ...
June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...